Work

Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade

Year: 2018

Type: article

Source: Cancer Letters

DOI: 10.1016/j.canlet.2018.10.003

Authors: Jing Zheng, Yonggang Sha, Logan Roof, Oded Foreman, John Lazarchick, Jagadish Kummetha Venkta, Cleopatra Kozlowski, Cristina Gasparetto, Nelson Chao, Allen Ebens, Jianda Hu, Yubin Kang

Institutions: Fujian Medical University, Duke University, Duke Medical Center, Union Hospital, University of Cincinnati Medical Center, Genentech, Medical University of South Carolina

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Genentech, Hollings Cancer Center, Medical University of South Carolina, National Heart, Lung, and Blood Institute, National Cancer Institute, Duke Cancer Institute

Awards: G1057259399, G1436149861, G3688917489, G3891775111, G53096212, Data commons for 'omic, microscopy and analysis core facilities, Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma, Medical University of South Carolina - Cancer Center Support Grant

OpenAlex ID: W2896086596

FWCI: 1.215

Cites: 44

Cited by: 20

Related to: 10